Catalyst Capital Advisors LLC Has $971,000 Stock Holdings in CME Group Inc. (NASDAQ:CME)

Catalyst Capital Advisors LLC boosted its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 256.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,662 shares of the financial services provider's stock after purchasing an additional 2,636 shares during the period. Catalyst Capital Advisors LLC's holdings in CME Group were worth $971,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of CME. SeaCrest Wealth Management LLC increased its holdings in CME Group by 3.0% during the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock worth $366,000 after buying an additional 40 shares during the last quarter. New Age Alpha Advisors LLC grew its position in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 43 shares during the period. Wealthcare Advisory Partners LLC increased its stake in shares of CME Group by 3.6% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock worth $356,000 after purchasing an additional 47 shares during the last quarter. Koshinski Asset Management Inc. raised its holdings in shares of CME Group by 1.4% in the 1st quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock valued at $934,000 after purchasing an additional 48 shares during the period. Finally, Berry Wealth Group LP lifted its stake in CME Group by 0.4% in the 1st quarter. Berry Wealth Group LP now owns 13,561 shares of the financial services provider's stock valued at $3,598,000 after purchasing an additional 49 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Bank of America boosted their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Raymond James Financial raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price on the stock in a report on Monday, March 10th. Oppenheimer increased their price target on CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. JPMorgan Chase & Co. reduced their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Finally, Citigroup upped their price objective on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $259.87.

CME Group Stock Performance

CME Group stock traded down $1.00 during midday trading on Friday, hitting $274.83. The company's stock had a trading volume of 1,234,017 shares, compared to its average volume of 2,194,406. The company has a 50-day moving average price of $276.23 and a two-hundred day moving average price of $257.62. CME Group Inc. has a 1-year low of $193.17 and a 1-year high of $290.79. The company has a market cap of $99.04 billion, a price-to-earnings ratio of 27.65, a PEG ratio of 3.75 and a beta of 0.44. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The business had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the previous year, the company posted $2.50 earnings per share. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio (DPR) is currently 50.30%.

Insider Buying and Selling

In other CME Group news, Director Dennis Suskind sold 1,000 shares of the company's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the sale, the director directly owned 2,915 shares in the company, valued at $790,781.20. This represents a 25.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Phyllis M. Lockett sold 1,060 shares of the firm's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the sale, the director directly owned 3,108 shares in the company, valued at approximately $863,651.04. This represents a 25.43% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,400 shares of company stock valued at $3,680,610 in the last ninety days. Insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.